We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGL icon
26
Arch Capital
ACGL
$33.7B
$3.64M 0.87%
36,060
+12,858
+55% +$1.25M
IWM icon
27
iShares Russell 2000 ETF
IWM
$80.8B
$3.43M 0.82%
16,920
+11,466
+210% +$2.32M
JNJ icon
28
Johnson & Johnson
JNJ
$646B
$3.35M 0.8%
22,900
-495
-2% -$73.6K
KO icon
29
Coca-Cola
KO
$386B
$3.3M 0.79%
51,783
-992
-2% -$61.4K
UNH icon
30
UnitedHealth
UNH
$353B
$3.24M 0.77%
6,368
+228
+4% +$112K
XOM icon
31
ExxonMobil
XOM
$644B
$3.13M 0.75%
27,177
-25
-0.1% -$2.91K
UNP icon
32
Union Pacific
UNP
$183B
$3.08M 0.74%
13,629
+150
+1% +$35.2K
EWBC icon
33
East-West Bancorp
EWBC
$17.7B
$2.97M 0.71%
40,525
+2,053
+5% +$152K
HD icon
34
Home Depot
HD
$329B
$2.89M 0.69%
8,389
+35
+0.4% +$11.9K
ABBV icon
35
AbbVie
ABBV
$451B
$2.62M 0.63%
15,298
-327
-2% -$54.2K
CSX icon
36
CSX Corp
CSX
$95B
$2.61M 0.62%
77,949
-196
-0.3% -$6.66K
LSXMA
37
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$2.49M 0.6%
112,628
-14,582
-11% -$348K
BRK.A icon
38
Berkshire Hathaway Class A
BRK.A
$1.08T
$2.45M 0.58%
4
– –
KR icon
39
Kroger
KR
$35.4B
$2.44M 0.58%
48,961
+186
+0.4% +$10K
PG icon
40
Procter & Gamble
PG
$334B
$2.35M 0.56%
14,256
+6
+0% +$981
CL icon
41
Colgate-Palmolive
CL
$72.3B
$2.27M 0.54%
23,389
+1
+0% +$92
ABT icon
42
Abbott
ABT
$195B
$2.16M 0.52%
20,808
-161
-0.8% -$17.1K
ETN icon
43
Eaton
ETN
$156B
$2.15M 0.51%
6,866
+66
+1% +$21.3K
IBB icon
44
iShares Biotechnology ETF
IBB
$10.5B
$2.13M 0.51%
15,526
-45
-0.3% -$6.01K
CRWD icon
45
CrowdStrike
CRWD
$224B
$2.01M 0.48%
20,936
-1,080
-5% -$89.8K
CRM icon
46
Salesforce
CRM
$211B
$1.93M 0.46%
7,491
+2,099
+39% +$562K
CP icon
47
Canadian Pacific Kansas City
CP
$82.7B
$1.67M 0.4%
21,209
– –
LLY icon
48
Eli Lilly
LLY
$1.05T
$1.59M 0.38%
1,758
-14
-0.8% -$11.2K
ANET icon
49
Arista Networks
ANET
$246B
$1.55M 0.37%
17,672
+1,872
+12% +$139K
MA icon
50
Mastercard
MA
$521B
$1.41M 0.34%
3,199
– –
1
2
3 4 5

Similar funds

EDRIA
Edmonds Duncan Registered Investment Advisors Lawrence, Kansas $457M AUM 23% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
AC
Albar Capital London, United Kingdom $445M AUM 55.79% 1-Year Est. Return
NIC
Northwest Investment Counselors Lake Oswego, Oregon $442M AUM 29.9% 1-Year Est. Return
WCA
Waypoint Capital Advisors Minneapolis, Minnesota $470M AUM 32.8% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
FPFS
First Personal Financial Services Charlotte, North Carolina $473M AUM 28.33% 1-Year Est. Return

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.